Table of Contents Author Guidelines Submit a Manuscript
Research Article
  • Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents, Amilton Dos Santos-Júnior, Taciane Barbosa Henriques, Maricilda Palandi de Mello, Osmar Henrique Della Torre, Lúcia Arisaka Paes, Adriana Perez Ferreira-Neto, Letícia Esposito Sewaybricker, Thiago Salum Fontana, Eloisa Helena Rubello Valler Celeri, Gil Guerra-Júnior, and Paulo Dalgalarrondo
    International Journal of Endocrinology
    Research Article (10 pages), Article ID 5872423, Volume 2016 (2016)
    Published 6 January 2016
International Journal of Endocrinology
Volume 2017, Article ID 8165368, 1 page
https://doi.org/10.1155/2017/8165368
Corrigendum

Corrigendum to “Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents”

1Department of Psychiatry, School of Medical Sciences (FCM), State University of Campinas (Unicamp), 13083-887 Campinas, SP, Brazil
2Laboratory of Human Genetics, Center for Molecular Biology and Genetic Engineering (CBMEG), Unicamp, 13083-875 Campinas, SP, Brazil
3Growth and Development Laboratory, Center for Investigation in Pediatrics (CIPED), FCM-Unicamp, 13083-887 Campinas, SP, Brazil
4Department of Pediatrics, Pediatric Endocrinology Unit, FCM-Unicamp, 13083-887 Campinas, SP, Brazil

Correspondence should be addressed to Osmar Henrique Della Torre; moc.liamg@qisp.ramso.rd

Received 5 January 2017; Accepted 19 April 2017; Published 16 May 2017

Copyright © 2017 Amilton Dos Santos-Júnior et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

This article has no abstract.